Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 9—September 2016
Research

Ebola Virus Disease, Democratic Republic of the Congo, 2014

Carolina Nanclares, Jimmy Kapetshi, Fanshen Lionetto, Olimpia de la Rosa, Jean-Jacques Muyembe Tamfun, Miriam Alia, Gary Kobinger, and Andrea BernasconiComments to Author 
Author affiliations: Médecins Sans Frontières, Barcelona, Spain (C. Nanclares, F. Lionetto, O. de la Rosa, M. Alia, A. Bernasconi); Institut National de Recherche Biomédicale, Kinshasha, Democratic Republic of the Congo (J. Kapetshi, J.-J. Muyembe Tamfun); Public Health Agency of Canada, Winnipeg, Manitoba, Canada (G. Kobinger); Swiss Tropical and Public Health Institute, Basel, Switzerland (A. Bernasconi); University of Basel, Basel (A. Bernasconi)

Main Article

Figure 1

Survival distribution (Kaplain-Meier) by sex of Ebola virus disease patients admitted to 2 Ebola treatment centers, Lokolia and Boende, Democratic Republic of the Congo, July–November 2014.

Figure 1. Survival distribution (Kaplain-Meier) by sex of Ebola virus disease patients admitted to 2 Ebola treatment centers, Lokolia and Boende, Democratic Republic of the Congo, July–November 2014.

Main Article

Page created: August 16, 2016
Page updated: August 16, 2016
Page reviewed: August 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external